Scientist Whose Discoveries Helped Develop Ipilimumab Among ASCO Honorees
The awards will be presented at ASCO's annual meeting to be held in Chicago in May this year.
Leaders in cancer care will be recognized as part of the American Society of Clinical Oncology Special Awards Program. The Special Awards recognize the dedication and significant contributions of researchers, patient advocates, and leaders of the global oncology community to enhancing cancer prevention, treatment, and patient care. Among this year's awardees are an international leader in geriatric oncology and a hematologic oncologist whose work has improved patient care and the education of health care providers in Honduras.
"This year's Special Awards recipients have made outstanding contributions to the field of oncology, leading a global effort to transform cancer care and improve the lives of people living with cancer," said Clifford A. Hudis, MD, FACP, Immediate Past President of ASCO and Chair of the Special Awards Selection Committee. "It is our honor to recognize their innovation and dedication with the highest honors that ASCO awards every year."
Source: ASCO press release
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025